Effect of Hepatic Impairment on LDE225..

Clinical trial NCT01764776 · COMPLETED

Trial details

NCT number: NCT01764776
Sponsor: Novartis Pharmaceuticals
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Normal Hepatic Function Impaired Hepatic Function

Start date: 2013-03-01
Primary completion: 2015-03-01
Enrollment: 33

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.